Kirkland Represents Danaher on $9.6 Billion Acquisition of Aldevron

Kirkland & Ellis advised Danaher Corporation (NYSE: DHR), a global science and technology innovator, on its acquisition of Aldevron from funds managed by EQT Private Equity and TA Associates for approximately $9.6 billion. Aldevron manufactures high-quality plasmid DNA, mRNA, and proteins, serving biotechnology and pharmaceutical customers across research, clinical and commercial applications. The transaction is subject to customary closing conditions.

Read the Danaher press release 

The Kirkland team was led by corporate partners Michael Brueck, Francisco Morales and Daniel Wolf and associate Patrick Salvo, and tax partners Dean Shulman and Tara Rhoades and associate Maria Smith.